Dentists in Kenosha, WI Accepting Medicare
105 Dentists found. Showing 101 - 105
 Dong Song, DDS Dentist Medicare: Medicare Enrolled Practice Location: 6430 Green Bay Rd, Kenosha, WI 53142 Phone: 888-988-4066 |
Dr. Dennis John Fahey, D.D.S. Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 3917 47th Ave, Kenosha, WI 53144 Phone: 262-656-1588 Fax: 262-656-1570 |
Robert C. Salituro, D.D.S Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 3515 75th St, Kenosha, WI 53142 Phone: 262-694-5858 Fax: 262-884-7212 |
Dr. Ferdinand Carl Chiappetta, DDS Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 6121 7th Ave, Kenosha, WI 53143 Phone: 262-654-6535 Fax: 262-654-3358 |
Dr. Benjamin David Berman, DDS Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 3600 80th St, Kenosha, WI 53142 Phone: 262-697-5444 |
News Archive
Massachusetts Health Connector renews contract to serve Commonwealth Care members
Centene Corporation today announced that the Massachusetts Health Connector has renewed its contract with Celtic Group's subsidiary, CeltiCare Health Plan of Massachusetts, to serve Commonwealth Care members, effective July 1, 2010.
Digitalisation, decentralisation and democratisation to be key technology trends for Australia's healthcare in 2015
Asia Pacific (APAC) is the fastest growing healthcare information technology (healthcare IT) market across the world. Within APAC, after Japan, Australia is the second largest market for health technology adoption.
VELCADE sNDA receives FDA approval
Millennium: The Takeda Oncology Company today announced that the U.S. Food and Drug Administration (FDA) has approved a supplemental new drug application (sNDA) for VELCADE, which expands the label to include long-term (median follow-up 36.7 months) overall survival (OS) data from the landmark VISTA trial and provides specific dosing recommendations for patients with hepatic impairment. The VISTA trial examined the use of VELCADE based therapy in patients with previously untreated multiple myeloma (MM).
Advanced lung cancer patients get survival benefit with use of concurrent chemotherapy, proton therapy
For patients with advanced, inoperable stage 3 lung cancer, concurrent chemotherapy and the specialized radiation treatment, proton therapy, offers improved survival compared to historical data for standard of care, according to a new study from The University of Texas MD Anderson Cancer Center.
› Verified 6 days ago
Counselors
Dentists
Pharmacists
Occupational Therapists
Clinical Social Workers
Psychologists